Diseases [C] » Neoplasms [C04] » Neoplastic Syndromes, Hereditary
Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Neoplastic Syndromes, Hereditary
Description
The condition of a pattern of malignancies within a family, but not every individual's necessarily having the same neoplasm. Characteristically the tumor tends to occur at an earlier than average age, individuals may have more than one primary tumor, the tumors may be multicentric, usually more than 25 percent of the individuals in direct lineal descent from the proband are affected, and the cancer predisposition in these families behaves as an autosomal dominant trait with about 60 percent penetrance. MeSH
Hierarchy View
Subtype Terms (14)
Adenomatous Polyposis Coli
31 drugs (14 approved, 17 experimental)
Basal Cell Nevus Syndrome
17 drugs (13 approved, 4 experimental)
Birt-Hogg-Dube Syndrome
2 approved drugs
Colorectal Neoplasms, Hereditary Nonpolyposis
20 drugs (16 approved, 4 experimental)
Dysplastic Nevus Syndrome
1 experimental drug
Exostoses, Multiple Hereditary
1 experimental drug
Hamartoma Syndrome, Multiple
6 drugs (3 approved, 3 experimental)
Hereditary Breast and Ovarian Cancer Syndrome
5 drugs (3 approved, 2 experimental)
Li-Fraumeni Syndrome
1 approved drug
Multiple Endocrine Neoplasia
4 drugs (3 approved, 1 experimental)
Neurofibromatoses
16 drugs (15 approved, 1 experimental)
Peutz-Jeghers Syndrome
3 approved drugs
Tuberous Sclerosis
13 drugs (10 approved, 3 experimental)
Wilms Tumor
82 drugs (49 approved, 33 experimental)
Phase 1 Indicated Drugs (2)
Organization Involved with Phase 2 Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
